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Abstract
While much effort has been made to characterize inﬂuenza A pdm09 virus (pH1N1), the ﬂu that was responsible for the fourth inﬂuenza
pandemic, there is a lack of study on the composition of bacteria that lead to secondary infection. In this study, we recruited pneumonia
patients with and without pH1N1 infection and characterized their oropharyngeal microbiota by the unbiased high-throughput sequencing
method. While there were no signiﬁcant differences in common bacterial pneumonia-causative agents (Acinetobacter and Streptococcus
species), previously unreported Pseudomonas species equipped with chemotaxis and ﬂagellar assembly genes signiﬁcantly increased (>20-
fold) in the pH1N1-infected group. Bacillus and Ralstonia species that also increased signiﬁcantly (5–10-fold) were also found to possess
similar signaling and motility genes. In contrast, no such genes were found in oral commensal Prevotella, Veillonella and Neisseria species,
which decreased signiﬁcantly, or in either Acinetobacter or 10 out of 21 Streptococcus species, including Streptococcus pneumoniae. Our
results support the notion that pH1N1 infection provides a niche for previously unnoticed potential respiratory pathogens that were able to
access the lower respiratory tract with weakened immunity.
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Introduction
Pneumonia, the sixth most common deadly disease, is usually
caused by bacteria, viruses or fungi. Among those infectious
agents identiﬁed, Streptococcus (S.) pneumoniae and Haemophilus
(H.) inﬂuenzae type b are the ﬁrst and second most common
causes of bacterial pneumonia, respectively. Respiratory syncy-
tial virus, humanmetapneumovirus and the parainﬂuenza viruses
are the leading viral causes of pneumonia in infants and children.
In March 2009, there was an outbreak of respiratory illness
caused by inﬂuenza A pdm09 virus (pH1N1) [1]. Although
most people infected by pH1N1 recovered, a signiﬁcant
number of patients were at risk of severe outcomes [2].
Compared with seasonal inﬂuenza, pH1N1 was able to
replicate in a respiratory tract region lower than the nasal
cavity and was more likely to cause viral pneumonia [3]. In
addition, pH1N1, but not seasonal inﬂuenza, was implicated in
gastrointestinal problems [1]. Inﬂuenza A virus can lead to
reduced levels of adrenocorticotropic hormone and cortisol,
and a decreased response of Toll-like receptor, which might in
turn inactivate the immune response [4]. Epithelium destruc-
tion by immune cells allows increased adhesion of bacteria to
the tracheal wall and thus better retention and growth of
pneumococci [5]. Excessive bacterial, and not viral, growth is
associated with increased lethality only in the presence of prior
ﬂu infection [6, 7].
There is only a single study that characterized the
composition of ﬂu-infected nasopharyngeal bacteria and the
study focus was the viral metagenome [8], and there is a lack
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of study on the differences between the microbiota of
pneumonia patients with and without pH1N1 infection. To
investigate whether there is any modulation of the compo-
sition of microbiota by pH1N1 in pneumonia patients, we
recruited throat swab samples from pneumonia patients with
and without pH1N1 infection and examined the differences
in the microbiota. Our results revealed the differential
microbiota in the two groups and discovered potential
respiratory pathogens previously overlooked. The enriched
bacteria in the pH1N1 patients were equipped with chemo-
taxis and ﬂagellar assembly genes, while the decreased ones
were not.
Materials and methods
Diagnosis criteria, microbiological tests, participant
enrollment and sample collection
Criteria for pneumonia include: (i) emerging cough and
sputum, (ii) purulent sputum accompanying worsening symp-
toms of pre-existing respiratory disease, (iii) fever (>37.4°C),
(iv) signs of consolidation in the lung and/or moist rales, (v)
number of white blood cell leukocytes >10 9 109/L
or < 4 9 109/L, and (vi) chest X-ray examination showing
sheets, patchy inﬁltration shadows or interstitial changes.
Patients who met two or more criteria including criterion (v)
were diagnosed as having pneumonia. Nonetheless, tubercu-
losis, pulmonary neoplasms, non-infectious interstitial lung
disease, pulmonary oedema, atelectasis, pulmonary embolism,
pulmonary eosinophil inﬁltration syndrome and pulmonary
vasculitis were excluded. Viral pneumonia due to inﬂuenza
virus infection was conﬁrmed when a positive laboratory test
(real-time PCR or cell culture) and criteria for pneumonia
were simultaneously met. Potential pathogens in patients with
inﬂuenza virus pneumonia were inspected as follows. The
bacteria isolated from induced sputum were considered to be
deﬁnitive causative pathogens and identiﬁed by VITEK
(BioMe´rieux, Craponne, France). For serological examinations,
a four-fold increase in the antibody titre level between paired
sera was considered deﬁnitive evidence. Based on the
examination results, the pneumonia patients who consulted
the Division of Respiratory Disease, the First Afﬁliated
Hospital of Guangzhou Medical College (Guangzhou, China),
from October 2009 to March 2010 were divided into two
groups: pneumonia without any inﬂuenza A infection (N)
(n = 11) and pneumonia with pH1N1 infection (pH1N1)
(n = 11). Their clinical features are summarized in Table 1.
This study was approved by the ethics committee of the First
Afﬁliated Hospital of Guangzhou Medical College and informed
consent was obtained for all subjects.
DNA extraction, ampliﬁcation and sequencing
Genomic DNA was extracted from throat swab samples with
the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) and
ampliﬁed with the Illustra GenomiPhi V2 DNA Ampliﬁcation
Kit (GE Healthcare, Waukesha, USA). Brieﬂy, 10 ng of
genomic DNA was mixed with 9 lL of sample buffer. The
mixture was heated to 95°C for 3 min and then cooled to 4°C
on ice. It was then transferred to the ampliﬁcation reaction
buffer and incubated at 30°C for 90 min and 65°C for 10 min.
The ampliﬁed genomic DNA samples were pooled together as
two groups (N and pH1N1) for sequencing using the Illumina
Solexa Sequencing Platform of the Beijing Genome Institute
Shenzhen.
Data analysis
All sequence reads obtained from each group were searched
against human, bacterial and viral genomes by the BLAST
algorithm [9]. To speed up the analysis, we ﬁrst evaluated our
data by assembling the reads into contiguous blocks (contigs)
and subjected them to a BLAST search against the nucleotide
databases in the National Center for Biotechnology Informa-
tion (NCBI) of the National Institute of Health, USA.
To minimize errors generated from mis-assembly, we then
searched all sequence reads directly against all completed or
draft genome sequences of humans (version 19), bacteria and
viruses using similar methods reported in our previous study
[10]. An e-value of 1e20 was chosen to trade-off between
sensitivity and speciﬁcity. Orthologs of representative bacterial
genomes were identiﬁed by OrthoMCL [11]. Protein func-
tionality analyses were carried out on COG and KEGG
annotation [12, 13]. The statistical signiﬁcance of fold-change
was estimated by DEGseq [14].
Results
Clinical characteristics of pneumonia patients
The recruited subjects were generally young in both groups
(as seen in Table 1) and gender balanced. All of them are of
the Han race. Five and four pH1N1 infected individuals
complained of headache and fatigue, respectively, but none
was found in the uninfected individuals. Four individuals
(36.4%, comparable to 38% mentioned in [1]) had gastro-
intestinal symptoms compared with one in the non-infected
group. U-tests were performed and the p-values for
headache, fatigue and gastrointestinal symptoms are 0.035,
0.074 and 0.139, respectively. Leucocytes and neutrophils
but not lymphocytes increased in the pH1N1-infected group.
The history of exposure and other clinical characteristics
displayed no signiﬁcant differences.
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Differential distribution of microbiota
The oropharyngeal microbiota (Fig. 1a) of both groups of
samples demonstrated phylum-level distribution, which most
resembled that of the oral cavity [15]. At family level,
Pseudomonadaceae, Moraxellacease and Bacillaceae in the
pH1N1 group (pH1N1) were signiﬁcantly more abundant than
the non-ﬂu infected pneumonia (N) patients. In contrast,
Prevotellacease, Veillonellaceae and Neisseriaceae decreased
signiﬁcantly (Fig. 1b, Table S1). At the genus level (Fig. 1c,
Table S1), the relative abundance of Pseudomonas, Ralstonia
and Bacillus recorded a signiﬁcant increase in the pH1N1
group. Also in accordance with the results at the family level,
Prevotella, Veillonella and Neisseria species decreased signif-
icantly in the pH1N1 group as expected.
We also searched the reads for the nearest matched species
at the nucleotide sequence level (Table S1). The relative
abundance of some previously unnoticed Pseudomonas species,
such as Pseudomonas (P.) amygdali, P. ﬂuorescens and Pseudomo-
nas sp. UK4, increased signiﬁcantly. Interestingly, Mycoplasma
pneumoniae (954 reads), a type of bacteria that often causes
slowly developing infection, was detected exclusively in the N
group, whileMycoplasma hyorhinis (231 reads), a primary agent of
enzootic pig pneumonia, was primarily found in the pH1N1
group (the N group only had two reads). However, other
TABLE 1. Clinical information and
diagnosis of participating pneumonia
patients
Characteristics
Pneumonia with
pH1N1 infection
(n = 11)a
Pneumonia
without pH1N1
infection (n = 11)a p-valueb
Demographic features
Age (years)
(median (IQR))
29 (16–62) 30 (16.5–49.5) 0.80
14–18a 4 (36.4) 4 (36.4)
19–30 3 (27.3) 2 (18.2)
31–44 0 (0) 2 (18.2)
45–64 2 (18.2) 2 (18.2)
 65 1 (9.1) 1 (9.1)
Male/female 5/6 8/3 0.66
Nation
Han 11 (100) 11 (100) 1
Others 0 (0) 0 (0) 1
Underlying conditions
Lung diseasec 2 (18.2) 1 (9.1) 1
Diabetes mellitus 0 (0) 1 (9.1) 1
Hypertension 1 (9.1) 1 (9.1) 1
Heart cerebrovascular disease 0 (0) 1 (9.1) 1
Liver disease 0 (0) 0 (0) 1
Other chronic diseased 0 (0) 0 (0) 1
Current smoker 0 (0) 3 (27.3) 0.21
History of similar exposure 3 (27.3) 1 (9.1) 0.59
Symptoms
Temperature ( )
(mean ± SD)e
38.34 ± 1.38 37.89 ± 1.20 0.30
<37.3 4 (44.4) 4 (36.4)
37.3–38 1 (11.1) 2 (18.2)
38.1–39 0 (0) 4 (36.4)
39.1–40 4 (44.4) 1 (9.1)
>40 0 (0) 0 (0)
Headache 5 (45.5) 0 (0) 0.04
Myalgia 3 (27.3) 1 (9.1) 0.59
Fatigue 4 (36.4) 0 (0) 0.09
Coryza 3 (27.3) 2 (18.2) 1
Sore throat 3 (27.3) 2 (18.2) 1
Dry cough 2 (18.2) 3 (27.3) 1
Sputum 7 (63.6) 8 (72.7) 1
Haemoptysis 0 (0) 0 (0) 1
Chest pain 1 (9.1) 1 (9.1) 1
Dyspnoea 1 (9.1) 3 (27.3) 0.59
Gastrointestinal symptomsf 4 (36.4) 1 (9.1) 0.31
Blood cell count, 9109/L, (mean ± SD)
Leucocyte 10.25 ± 8.07 7.80 ± 4.57 0.56
Neutrophil 8.01 ± 7.76 5.19 ± 4.17 0.33
Lymphocyte 1.3 ± 0.44 1.71 ± 0.64 0.12
Primary diagnosis
Pneumonia 9 (81.8) 8 (72.7) 1
Acute bronchitis 0 (0) 1 (9.1) 1
Pneumothorax 0 (0) 0 (0) 1
Asthma 0 (0) 1 (9.1) 1
Upper respiratory
tract infection
1 (9.1) 0 (0) 1
aData are shown as number (%) unless otherwise speciﬁed.
bThe Mann–Whitney two-sample test and chi-square test were used as appropriate.
cLung disease was deﬁned as chronic obstructive pulmonary disease, asthma, bronchiectasis, interstitial lung disease
and cancer.
dOther chronic diseases include kidney diseases, endocrine disease (excluding diabetes), haematologic disease,
chronic disease of nervous system (excluding cerebrovascular disease), and gastrointestinal disease.
eDenotes the highest body temperature of feverish patients before and on admission to hospital.
fGastrointestinal symptoms included nausea, vomiting, diarrhoea, abdominal pain and abdominal distention.
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common bacterial pneumonia causative agents, including
H. inﬂuenzae, S. pneumoniae, Moraxella catarrhalis and Neisseria
meningitidis, only accounted for a very small proportion (<1500
reads in the two samples in total) in the oropharynx and did not
vary signiﬁcantly between the two groups of samples; so did the
other respiratory disease causative agents such as Bordetella
parapertussis and Bordetella bronchiseptica (two reads). The rarity
of these common respiratory bacterial pathogens reported by
high-throughput sequencing is concordant with the primary
diagnosis result. HACEK organisms, which comprise normal
oropharyngeal ﬂora, were found to decrease in the pH1N1
group as expected, when estimated at the genus level (N, 1670;
pH1N1, 337).
Identiﬁcation of bacteria present in the pH1N1 group
To unravel the identity of bacteria present in the pH1N1 group,
we assembled our pair-end reads of sequences and into
contiguous blocks (contigs) of length of 500bp or above. This
reduces the chance of matching homologous regions shared by
different bacteria. Searching the contigs against the public
nucleotide database in NCBI yielded 11 and 162 hits that had top
matches of Ralstonia picketti and P. ﬂuorescens, respectively,
covering various regions of the genome. While the former was
almost exactly matched (matches of 100% similarity, 7; >99.5%,
2; >80%, 2), there existed a signiﬁcant number of protein coding
sequences that did not have high similarity to the homologues of
P. ﬂuorescens (30–40%, 3; 40–50%, 6; 50–60%, 5; 60–70%, 8; 70–
80%, 13; 80–90%, 24; 90–100%, 103). Previously unreported
Pseudomonas species were likely to be present in pH1N1
infected patients.
Functional capacity of enriched microbiota in the pH1N1
group
Species from the pH1N1 and N groups containing COG
annotation that showed differential abundance were examined
regarding differences of functional genes. We found that only
the pH1N1 group contained COGs involved in cell motility,
signal transduction mechanisms, inorganic ion transport and
metabolism, secondary metabolites biosynthesis/transport/
catabolism, and transcription regulation (Table S2).
In particular, cell motility and signal transduction associated
proteins were obviously much enriched and therefore we
examined their speciﬁc functions (Table S3): bacterial chemo-
taxis and ﬂagellum assembly. It is possible that these genes
enable the bacteria to sense the niche created by pH1N1
infection and accordingly synthesize machinery to reach
potential nutrient-rich environments.
To study whether the ﬁndings can be generalized, under
categories ‘chemotaxis’ and ‘ﬂagellar assembly’ in the KEGG
database, we examined all the bacteria that are equipped with
these two kinds of genes. Surprisingly, Prevotella, Veillonella,
Neisseria, Acinetobacter and 10 out of 21 Streptococcus
species (including S. pneumoniae) lack chemotaxis genes and all
the species in these ﬁve genera lack ﬂagellar genes.
Discussion
Because ampliﬁed genomic DNA samples were pooled
together for the two groups of patients, signiﬁcant differences
(a)
(b)
(c)
FIG. 1. Relative abundance of pH1N1-infected and uninfected pneu-
monia patients, at (a) the phylum level, (b) the family level and (c) the
genus level. *Represents p-value < 0.05.
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between the two groups could be over-represented in only
one of the samples. Moreover, our studies could not detect
important RNA viruses, such as inﬂuenza viruses A and B,
respiratory syncytial virus and human parainﬂuenza viruses.
This problem could be overcome by collecting RNA samples
for unbiased high-throughput sequencing in the future.
Inﬂuenza complications are common and secondary bacte-
rial pneumonia can be fatal. In our study, a signiﬁcant amount
of previously unnoticed bacteria was found to comprise the
oropharyngeal microbiota of pH1N1-infected patients but not
the uninfected pneumonia patients. Unexpected pathogenic
bacteria were also reported in a recent study of bacteria in
bronchoalveolar lavage ﬂuid from children with cystic ﬁbrosis
[16]. These results indicate that there is a need to develop
more sensitive techniques for better potential pathogen
detection.
Although the oropharynx is an environment that contains
heterogeneous sources of air- and food-borne microbes, the
normal oropharyngeal microbiota is relatively stable and large
perturbations usually signify infections. Recent reports suggest
that microbiota disturbance is associated with the develop-
ment of lung diseases such as asthma and COPD [17–19]. In
both asthmatic and COPD patients [19], the relative abun-
dance of Bacteroidetes, particularly Prevotella species, was
found to decrease signiﬁcantly. The aforementioned ﬁndings
are consistent with our ﬁnding and pH1N1 might be respon-
sible for the modulation.
As microﬂora can establish cooperation, competition or a
hybrid inter-relationship, we cannot conclude whether the
observed increase in potential opportunistic pathogens and
decrease in oral commensal species simply reﬂected solely the
increase of the former, decrease of the latter, or both. Despite
constant challenges from microorganisms that originate from
the naso- and oropharynx, healthy individuals are equipped
with immunity and physical barriers that may purge, keep out
or destroy potential respiratory pathogens that may affect the
lower respiratory tract. However, when our mucociliary
escalator is damaged by pH1N1 infection, more bacteria are
then able to enter the lower respiratory tract. COG
enrichment and KEGG analysis results support the idea that
enriched bacteria in the pH1N1 group were better equipped
with proteins that participate in cell motility and signal
transduction.
Chemotaxis, a commonly observed phenomenon in living
organisms, is involved in a wide array of biological processes,
including development, defence, nutrient acquisition and
damage avoidance [20]. In this study, we have identiﬁed that
signiﬁcantly increased bacterial species in the pH1N1 group
are equipped with chemotaxis and ﬂagellar assembly genes,
while the decreased bacterial species are not. The signiﬁcance
of chemotaxis and ﬂagellar genes biosynthesis has also been
reported in other bacteria such as Escherichia coli and
Rhizobium leguminosarum [21, 22].
Contig analysis suggests the presence of previously unre-
ported species, in particular Pseudomonas species. It is noted
that a lot of reads were mapped to P. ﬂuorescens and this
bacterium had been associated with ventilator-associated
pneumonia [23], damage to nerve and epithelial intestinal cells
and bacteraemia [24–26]. The possibility of transmission
through faecal viral shedding and subsequent faecal-oral
contact cannot be ruled out, because more pH1N1-infected
patients had gastrointestinal problems and P. ﬂuorescens is
associated with Crohn’s disease [27]. Nonetheless, careful
interpretation is needed as P. ﬂuorescens genomes are highly
diverse and our results also showed large variation from the
reference genome (P. ﬂuorescens Pﬂ-5) [28]. Conventional
culturing techniques and polymerase chain reaction using
design primers speciﬁc for the Pseudomonas community can
help elucidate the composition of these potentially pathogenic
species.
In conclusion, our study revealed previously unnoticed
potential respiratory pathogens and suggested that prior
pH1N1 infection may facilitate the colonization of opportu-
nistic pathogens that are able to gain better access to the
lower respiratory tract by chemotaxis and cell motility genes.
In contrast, commensal microﬂora that lack these genes may
be at a disadvantage and as a result decrease in relative
abundance. Further efforts should be made to identify the
potential pathogens so that more appropriate and prompt
treatment can be received. Such results would help plan for
the next wave of pandemic inﬂuenza [29], as well as boost the
chance of survival for those who are prone to aspiration
pneumonia [30].
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